Publication: 4437

Publication: 4437

Trial in Progress – Alliance A051901 – Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (Nivo-MR2) Induction followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma (PCNSL)

DOI

URL

Google Scholar

Citation:: Blood vol 144 (Supplement 1) 4502.4

Meeting Instance:: ASH 2024
Year:: 2024
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epreprint

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171

Corr. Author:
Authors:: Alvaro J. Alencar Olivia Bobek Neha Mehta-Shah Narendranath Epperla Christine Lu-Emerson Sarah Rutherford Adam Olszewski Thomas Ollila Samuel Singer Travis J. Dockter Susan Geyer Lori J. Rosenstein Macarena De La Fuente Eric Hsi Shira Dinner James Rubenstein Nancy Bartlett John P. Leonard

Networks:: CA824, FL028, LAPS-IL036, LAPS-MN026, LAPS-MO011, LAPS-NY016, LAPS-UT003, MAINE, NY018, RI005, WINCORP

Study: Alliance-A051901
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1

Keywords: